Zobrazeno 1 - 10
of 124
pro vyhledávání: '"incomplete Freund's adjuvant"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Marit M. Melssen, Gina R. Petroni, Kimberly A. Chianese-Bullock, Nolan A. Wages, William W. Grosh, Nikole Varhegyi, Mark E. Smolkin, Kelly T. Smith, Nadejda V. Galeassi, Donna H. Deacon, Elizabeth M. Gaughan, Craig L. Slingluff
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-13 (2019)
Abstract Background Cancer vaccines require adjuvants to induce effective immune responses; however, there is no consensus on optimal adjuvants. We hypothesized that toll-like receptor (TLR)3 agonist polyICLC or TLR4 agonist lipopolysaccharide (LPS),
Externí odkaz:
https://doaj.org/article/a8026c4ba7c5475c8be9506d9626cbab
Autor:
Zhengqing Yu, Wenxi Ding, Muhammad Tahir Aleem, Junzhi Su, Junlong Liu, Jianxun Luo, Ruofeng Yan, Lixin Xu, Xiaokai Song, Xiangrui Li
Publikováno v:
Pharmaceutics, Vol 13, Iss 5, p 752 (2021)
As an important zoonotic protozoan, Toxoplasma gondii (T. gondii) has spread around the world, leading to infections in one-third of the population. There is still no effective vaccine or medicine against T. gondii, and recombinant antigens entrapped
Externí odkaz:
https://doaj.org/article/ddd5505f2cc441d09c6d2ec58d66cd6c
Autor:
Sherry Thornton, Richard T. Strait
Publikováno v:
BioTechniques, Vol 60, Iss 3, Pp 119-128 (2016)
Collagen-induced arthritis (CIA) is a widely used mouse model for studying inflammatory arthritis (IA). However, CIA induction protocols differ between laboratories, and direct comparison between protocol variations has not been reported. To address
Externí odkaz:
https://doaj.org/article/ee0ab6d14e6d4ffeac954d12f1e81296
Autor:
Viromi Fernando, Seiichi Omura, Fumitaka Sato, Eiichiro Kawai, Nicholas E. Martinez, Sadie Faith Elliott, Keigyou Yoh, Satoru Takahashi, Ikuo Tsunoda
Publikováno v:
International Journal of Molecular Sciences, Vol 15, Iss 2, Pp 1700-1718 (2014)
T helper (Th)2 cells have been proposed to play a neuroprotective role in multiple sclerosis (MS). This is mainly based on “loss-of-function” studies in an animal model for MS, experimental autoimmune encephalomyelitis (EAE), using blocking antib
Externí odkaz:
https://doaj.org/article/1551098ca2f6473d9b3407929a5b89f6
Autor:
Korn, Thomas, Mitsdoerffer, Meike, Croxford, Andrew L., Awasthi, Amit, Dardalhon, Valérie A., Galileos, George, Vollmar, Patrick, Stritesky, Gretta L., Kaplan, Mark H., Waisman, Ari, Kuchroo, Vijay K., Oukka, Mohamed
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 2008 Nov . 105(47), 18460-18465.
Externí odkaz:
https://www.jstor.org/stable/25465483
Publikováno v:
Pakistan Veterinary Journal, Vol 24, Iss 4, Pp 179-183 (2004)
The early and accurate diagnosis of infectious bursal disease requires known hyperimmune serum against the disease. In this study, an attempt was made to raise anti-infectious bursal disease virus hyperimmune serum in rabbits. The infectious bursal d
Externí odkaz:
https://doaj.org/article/a780fb91ecb142799b0f1a20f8851c0a
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Craig L. Slingluff, Nadejda V. Galeassi, Kelly T. Smith, Marit M. Melssen, Kimberly A. Chianese-Bullock, Mark E. Smolkin, Nolan A. Wages, Elizabeth M. Gaughan, Donna H. Deacon, Gina R. Petroni, Nikole Varhegyi, William W. Grosh
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-13 (2019)
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer
Background Cancer vaccines require adjuvants to induce effective immune responses; however, there is no consensus on optimal adjuvants. We hypothesized that toll-like receptor (TLR)3 agonist polyICLC or TLR4 agonist lipopolysaccharide (LPS), combined
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87f92b4c74f6e58cb15e90ed2dbfd238
https://doi.org/10.1186/s40425-019-0625-x
https://doi.org/10.1186/s40425-019-0625-x